Position in AMLX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$78,535,000
+$10,283,000 QoQ
Shares Held
5,650,000
0.0% QoQ
Ownership
5.08%
of shares outstanding
% of Portfolio
4.54%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in AMLX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Commodore Capital LP holds $227,047,000 across 2 Drug Manufacturers - Specialty & Generic names. AMLX ranks #2 (34.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALKS |
Alkermes plc.
|
4,200,000 | $148,512,000 | |
| 2 | AMLX |
Amylyx Pharmaceuticals, Inc.
This page
|
5,650,000 | $78,535,000 |
All Filings in AMLX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $78,535,000 | 5,650,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $68,252,000 | 5,650,000 | Shares | Sole | 2026-02-17 | |
| 2025-11-10 | $68,817,000 | 5,650,000 | Shares | Sole | 2025-11-17 | |
| 2025-09-30 | $55,385,746 | 4,075,478 | Shares | Sole | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||